CTRI/2018/09/015608
Not yet recruiting
未知
Clinical study to assess the effectiveness of Vamana karma with madanaphala patra in ekakushta (psoriasis)
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Eka kushta(Psoriasis)
- Sponsor
- Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients who are fit for vamana.
- •2\.Who are willing to participate and sign informed consent form.
Exclusion Criteria
- •a)Patients with complications of psoriasis.
- •b)Cases of diabetes mellitus , hypertension , HIV , HBsAg , carcinoma.
- •c)Subjects with impaired cardiac function , impaired renal function , impaired hepatic function.
- •d) Signs of systemc infections.
- •e)Pregnant women and lactating mother
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Treatment for menstrual period problems by panchakarma therapy and ayurvedic medicineHealth Condition 1: E749- Disorder of carbohydrate metabolism, unspecifiedHealth Condition 2: null- PCOS DIAGNOSED CASES OF AGE GROUP 20 TO 40 YRS WHICH ARE FIT FOR VAMANA AND BASTIKARMACTRI/2017/02/007825ational Institute of Ayurveda30
Not yet recruiting
Phase 3
Effect of vamana karma(therapeutic emessis) and Kustumburaadi lepa in Yuvanpidika (Acne vulgaris)Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereCTRI/2022/06/043088Government PG Ayurveda college and hospital Varanasi
Not yet recruiting
Phase 1
Panchakarma, Ayurveda, Emesis, Powder massage, hypothyroidismHealth Condition 1: - Health Condition 2: E02- Subclinical iodine-deficiency hypothyroidismCTRI/2020/01/022809Dr Mallika Singh
Active, not recruiting
Phase 1
Clinical study to investigate whether in patients with peripheral artery disease, after implantation of a stent and showing high platelet reactivity during treatment with clopidogrel, treatment with ticagrelor is able to prevent effectively vascular occlusioEUCTR2014-001989-97-ATOA Doz. Dr. Thomas Müller c/o B&S Zentrallabor Konventhospital Barmherzige Brüder Linz500
Not yet recruiting
Not Applicable
Role of Emesis in Treatment of Thyroid DiseaseHealth Condition 1: E038- Other specified hypothyroidismCTRI/2019/06/019735Dr Shawn Kumar